Applied Therapeutics (FRA:2UV) Current Accrued Expense : €7.30 Mil (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Applied Therapeutics Current Accrued Expense?

Applied Therapeutics's Current Accrued Expense for the quarter that ended in Mar. 2025 was €7.30 Mil.

Applied Therapeutics's quarterly Current Accrued Expense increased from Sep. 2024 (€9.64 Mil) to Dec. 2024 (€10.80 Mil) but then declined from Dec. 2024 (€10.80 Mil) to Mar. 2025 (€7.30 Mil).

Applied Therapeutics's annual Current Accrued Expense increased from Dec. 2022 (€10.72 Mil) to Dec. 2023 (€10.88 Mil) but then declined from Dec. 2023 (€10.88 Mil) to Dec. 2024 (€10.80 Mil).

Applied Therapeutics Current Accrued Expense Historical Data

The historical data trend for Applied Therapeutics's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied Therapeutics Current Accrued Expense Chart

Applied Therapeutics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Current Accrued Expense

Get a 7-Day Free Trial

13.53

10.62

10.72

10.88

10.80

Applied Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Current Accrued Expense	Get a 7-Day Free Trial															11.23	7.10	9.64	10.80	7.30

Applied Therapeutics Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Applied Therapeutics Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Applied Therapeutics's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Applied Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Applied Therapeutics Inc (FRA:2UV) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

APLT:USA 2UV:Germany

Address

545 Fifth Avenue, Suite 1400, New York, NY, USA, 10017

Website

https://www.appliedtherapeutics.com

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Applied Therapeutics Headlines

No Headlines